Circulating Biomarker for Liquid Biopsy Market
1 Introduction to Research & Analysis Reports
1.1 Circulating Biomarker for Liquid Biopsy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Circulating Biomarker for Liquid Biopsy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Circulating Biomarker for Liquid Biopsy Overall Market Size
2.1 Global Circulating Biomarker for Liquid Biopsy Market Size: 2021 VS 2028
2.2 Global Circulating Biomarker for Liquid Biopsy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Circulating Biomarker for Liquid Biopsy Players in Global Market
3.2 Top Global Circulating Biomarker for Liquid Biopsy Companies Ranked by Revenue
3.3 Global Circulating Biomarker for Liquid Biopsy Revenue by Companies
3.4 Top 3 and Top 5 Circulating Biomarker for Liquid Biopsy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Circulating Biomarker for Liquid Biopsy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Circulating Biomarker for Liquid Biopsy Players in Global Market
3.6.1 List of Global Tier 1 Circulating Biomarker for Liquid Biopsy Companies
3.6.2 List of Global Tier 2 and Tier 3 Circulating Biomarker for Liquid Biopsy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Circulating Biomarker for Liquid Biopsy Market Size Markets, 2021 & 2028
4.1.2 Circulating Tumor Cells (CTCs)
4.1.3 Circulating Tumor DNA (ctDNA)
4.1.4 Cell-Free DNA (cfDNA)
4.1.5 Extracellular Vesicles (EVs)
4.1.6 Others
4.2 By Type - Global Circulating Biomarker for Liquid Biopsy Revenue & Forecasts
4.2.1 By Type - Global Circulating Biomarker for Liquid Biopsy Revenue, 2017-2022
4.2.2 By Type - Global Circulating Biomarker for Liquid Biopsy Revenue, 2023-2028
4.2.3 By Type - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Circulating Biomarker for Liquid Biopsy Market Size, 2021 & 2028
5.1.2 Early Cancer Screening
5.1.3 Therapy Selection
5.1.4 Treatment Monitoring
5.1.5 Recurrence Monitoring Orthopedics
5.2 By Application - Global Circulating Biomarker for Liquid Biopsy Revenue & Forecasts
5.2.1 By Application - Global Circulating Biomarker for Liquid Biopsy Revenue, 2017-2022
5.2.2 By Application - Global Circulating Biomarker for Liquid Biopsy Revenue, 2023-2028
5.2.3 By Application - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Circulating Biomarker for Liquid Biopsy Market Size, 2021 & 2028
6.2 By Region - Global Circulating Biomarker for Liquid Biopsy Revenue & Forecasts
6.2.1 By Region - Global Circulating Biomarker for Liquid Biopsy Revenue, 2017-2022
6.2.2 By Region - Global Circulating Biomarker for Liquid Biopsy Revenue, 2023-2028
6.2.3 By Region - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Circulating Biomarker for Liquid Biopsy Revenue, 2017-2028
6.3.2 US Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.3.3 Canada Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.3.4 Mexico Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Circulating Biomarker for Liquid Biopsy Revenue, 2017-2028
6.4.2 Germany Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.4.3 France Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.4.4 U.K. Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.4.5 Italy Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.4.6 Russia Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.4.7 Nordic Countries Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.4.8 Benelux Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Circulating Biomarker for Liquid Biopsy Revenue, 2017-2028
6.5.2 China Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.5.3 Japan Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.5.4 South Korea Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.5.5 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.5.6 India Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Circulating Biomarker for Liquid Biopsy Revenue, 2017-2028
6.6.2 Brazil Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.6.3 Argentina Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Circulating Biomarker for Liquid Biopsy Revenue, 2017-2028
6.7.2 Turkey Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.7.3 Israel Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.7.4 Saudi Arabia Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
6.7.5 UAE Circulating Biomarker for Liquid Biopsy Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.1.4 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Becton, Dickinson and Company
7.2.1 Becton, Dickinson and Company Corporate Summary
7.2.2 Becton, Dickinson and Company Business Overview
7.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.2.4 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2017-2022)
7.2.5 Becton, Dickinson and Company Key News
7.3 GE Healthcare
7.3.1 GE Healthcare Corporate Summary
7.3.2 GE Healthcare Business Overview
7.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.3.4 GE Healthcare Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2017-2022)
7.3.5 GE Healthcare Key News
7.4 Epigenomics AG
7.4.1 Epigenomics AG Corporate Summary
7.4.2 Epigenomics AG Business Overview
7.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.4.4 Epigenomics AG Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2017-2022)
7.4.5 Epigenomics AG Key News
7.5 Agilent Technologies
7.5.1 Agilent Technologies Corporate Summary
7.5.2 Agilent Technologies Business Overview
7.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.5.4 Agilent Technologies Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2017-2022)
7.5.5 Agilent Technologies Key News
7.6 Biocept
7.6.1 Biocept Corporate Summary
7.6.2 Biocept Business Overview
7.6.3 Biocept Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.6.4 Biocept Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2017-2022)
7.6.5 Biocept Key News
7.7 Affymetrix
7.7.1 Affymetrix Corporate Summary
7.7.2 Affymetrix Business Overview
7.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.7.4 Affymetrix Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2017-2022)
7.7.5 Affymetrix Key News
7.8 Fluxion Biosciences
7.8.1 Fluxion Biosciences Corporate Summary
7.8.2 Fluxion Biosciences Business Overview
7.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.8.4 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2017-2022)
7.8.5 Fluxion Biosciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Circulating Biomarker for Liquid Biopsy Market Opportunities & Trends in Global Market
Table 2. Circulating Biomarker for Liquid Biopsy Market Drivers in Global Market
Table 3. Circulating Biomarker for Liquid Biopsy Market Restraints in Global Market
Table 4. Key Players of Circulating Biomarker for Liquid Biopsy in Global Market
Table 5. Top Circulating Biomarker for Liquid Biopsy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Circulating Biomarker for Liquid Biopsy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Circulating Biomarker for Liquid Biopsy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Circulating Biomarker for Liquid Biopsy Product Type
Table 9. List of Global Tier 1 Circulating Biomarker for Liquid Biopsy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Circulating Biomarker for Liquid Biopsy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Circulating Biomarker for Liquid Biopsy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Circulating Biomarker for Liquid Biopsy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Circulating Biomarker for Liquid Biopsy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Circulating Biomarker for Liquid Biopsy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product Offerings
Table 32. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 33. Becton, Dickinson and Company Corporate Summary
Table 34. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product Offerings
Table 35. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 36. GE Healthcare Corporate Summary
Table 37. GE Healthcare Circulating Biomarker for Liquid Biopsy Product Offerings
Table 38. GE Healthcare Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 39. Epigenomics AG Corporate Summary
Table 40. Epigenomics AG Circulating Biomarker for Liquid Biopsy Product Offerings
Table 41. Epigenomics AG Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 42. Agilent Technologies Corporate Summary
Table 43. Agilent Technologies Circulating Biomarker for Liquid Biopsy Product Offerings
Table 44. Agilent Technologies Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 45. Biocept Corporate Summary
Table 46. Biocept Circulating Biomarker for Liquid Biopsy Product Offerings
Table 47. Biocept Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 48. Affymetrix Corporate Summary
Table 49. Affymetrix Circulating Biomarker for Liquid Biopsy Product Offerings
Table 50. Affymetrix Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 51. Fluxion Biosciences Corporate Summary
Table 52. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product Offerings
Table 53. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Circulating Biomarker for Liquid Biopsy Segment by Type in 2021
Figure 2. Circulating Biomarker for Liquid Biopsy Segment by Application in 2021
Figure 3. Global Circulating Biomarker for Liquid Biopsy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Circulating Biomarker for Liquid Biopsy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Circulating Biomarker for Liquid Biopsy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue in 2021
Figure 8. By Type - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2017-2028
Figure 12. US Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2017-2028
Figure 16. Germany Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 17. France Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2017-2028
Figure 24. China Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 28. India Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2017-2028
Figure 30. Brazil Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2017-2028
Figure 33. Turkey Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GE Healthcare Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Epigenomics AG Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Agilent Technologies Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Biocept Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Affymetrix Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
